Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8


SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells.

Tumbarello DA, Andrews MR, Brenton JD.

PLoS One. 2016 Sep 13;11(9):e0162698. doi: 10.1371/journal.pone.0162698. eCollection 2016.


Insidious changes in stromal matrix fuel cancer progression.

Miles FL, Sikes RA.

Mol Cancer Res. 2014 Mar;12(3):297-312. doi: 10.1158/1541-7786.MCR-13-0535. Epub 2014 Jan 22. Review.


Loss of SPARC in bladder cancer enhances carcinogenesis and progression.

Said N, Frierson HF, Sanchez-Carbayo M, Brekken RA, Theodorescu D.

J Clin Invest. 2013 Feb;123(2):751-66. doi: 10.1172/JCI64782. Epub 2013 Jan 16. Erratum in: J Clin Invest. 2013 Sep 3;123(9):4089.


Aberrant methylation of secreted protein, acidic and rich in cysteine in human laryngeal and hypopharyngeal carcinoma.

He Q, Wei J, Zhang J, Jiang H, Wang S, Zhou X, Zhang Z, Huang G, Watanabe H, Su J.

Oncol Lett. 2011 Jul;2(4):725-729. Epub 2011 May 5.


ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.

Tumbarello DA, Temple J, Brenton JD.

Mol Cancer. 2012 May 28;11:36. doi: 10.1186/1476-4598-11-36.


Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival.

Schultz CR, Golembieski WA, King DA, Brown SL, Brodie C, Rempel SA.

Mol Cancer. 2012 Apr 5;11:20. doi: 10.1186/1476-4598-11-20.


Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression.

Sprenger CC, Plymate SR, Reed MJ.

Int J Cancer. 2010 Dec 15;127(12):2739-48. doi: 10.1002/ijc.25615. Epub 2010 Oct 8. Review.


SPARC: a matricellular regulator of tumorigenesis.

Arnold SA, Brekken RA.

J Cell Commun Signal. 2009 Dec;3(3-4):255-73. doi: 10.1007/s12079-009-0072-4. Epub 2009 Oct 7.

Supplemental Content

Support Center